4
Changes in Ownership
CalciMedica, Inc. Filed Acc 0001415889-25-011362
Options or other derivatives
- Chief Scientific Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Stauderman Kenneth A. Chief Scientific Officer | 2025-04-23 | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | D | ||
Loading xslF345X05/form4-04252025_080402.xml…